| __timestamp | Amneal Pharmaceuticals, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 1392830 |
| Thursday, January 1, 2015 | 109679000 | 2419289 |
| Friday, January 1, 2016 | 118757000 | 6343648 |
| Sunday, January 1, 2017 | 109046000 | 7206691 |
| Monday, January 1, 2018 | 230435000 | 9351522 |
| Tuesday, January 1, 2019 | 289598000 | 13598030 |
| Wednesday, January 1, 2020 | 326727000 | 28896749 |
| Friday, January 1, 2021 | 365504000 | 66646205 |
| Saturday, January 1, 2022 | 399700000 | 159253661 |
| Sunday, January 1, 2023 | 429675000 | 323123000 |
| Monday, January 1, 2024 | 411359000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding the financial strategies of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Axsome Therapeutics, Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Amneal Pharmaceuticals consistently outpaced Axsome Therapeutics in SG&A spending, with a peak in 2023 where their expenses were approximately 33% higher than Axsome's. Notably, Axsome's SG&A expenses surged by over 23,000% from 2014 to 2023, reflecting their aggressive growth strategy. Meanwhile, Amneal's expenses grew by about 400%, indicating a steady expansion. This financial narrative highlights the contrasting approaches of these two industry players, offering insights into their operational priorities and market positioning.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Axsome Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Catalent, Inc. or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Axsome Therapeutics, Inc.
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Axsome Therapeutics, Inc. or Verona Pharma plc: Who Manages SG&A Costs Better?
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Axsome Therapeutics, Inc. and Novavax, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?